March 5, 2012 — Baxter International Inc. announced that it initiated a phase III pivotal clinical trial to evaluate the efficacy and safety of adult autologous (individual’s own) CD34+ stem cells to increase exercise capacity in patients with chronic myocardial ischemia (CMI).

March 1, 2012 — Cell>Point announced it entered into a licensing agreement for South Korea, Taiwan, Malaysia, Vietnam and the Philippines with Hyun Imc Co. Ltd., headquartered in Seoul, South Korea, for the kit manufacture, marketing and distribution of Cell>Point’s cancer and cardiology nuclear imaging product.

March 1, 2012 — Philips announced the launch of HeartStart XL+, a crash cart defibrillator/monitor for use in hospitals and other health care facilities that, in AED mode, can defibrillate any patient with no special pads required, which can save valuable time when responding to a cardiac emergency.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now